Jane Davies

Davies joined the National Heart and Lung Institute in 1999, where she has specialised in cystic fibrosis. Davies has been involved with the UK CF Gene Therapy Consortium since it was established in 2002. Davies worked on the development of Cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy. She led the first trials of CFTR modulators in young children. She conducts bronchoscopic assays and electrophysiological measurements. She was made a Reader in 2009 and a Professor in 2013. Davies investigates cystic fibrosis. She was involved with a major UK trial of gene therapy for cystic fibrosis.

Davies studied medicine at the University of Dundee. She graduated in 1987, and began paediatric training in London. She began to work at the Royal Brompton Hospital on cystic fibrosis. She earned her MD on host-pathogen interactions under the supervision of Andrew Bush and Eric Alton. She looked at the pathogensis of Pseudomonas aeruginosa. She worked at Great Ormond Street Hospital.

Jane C. Davies (born 9 November 1963) is a British physician who is Professor of Paediatric Respirology at Imperial College School of Medicine. She is an Honorary Consultant at the Royal Brompton and Harefield NHS Foundation Trust.